Mabworks Biotech Patents – Insights & Stats (Updated 2024)

Mabworks Biotech has a total of 147 patents globally, out of which 63 have been granted. Of these 147 patents, more than 71% patents are active. China is where Mabworks Biotech has filed the maximum number of patents, followed by United states of America and Hong Kong (S.A.R.). Parallelly, China seems to be the main focused R&D centre and also is the origin country of Mabworks Biotech.

Mabworks Biotech was founded in 2002. The company develops specialized antibody drugs focused on cancer biology. With expertise in creating pre-clinical and clinical drugs for tumors and autoimmune diseases, the company leverages advance in immunology and cancer biology to support research and pharmaceutical solutions for disease treatment.

Do read about some of the most popular patents of Mabworks Biotech which have been covered by us in this article and also you can find Mabworks Biotech patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Mabworks Biotech patent portfolio.

How many patents does Mabworks Biotech have?

Mabworks Biotech has a total of 147 patents globally. These patents belong to 47 unique patent families. Out of 147 patents, 105 patents are active.

How Many Patents did Mabworks Biotech File Every Year?

Mabworks Biotech patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantMabworks Biotech Applications FiledMabworks Biotech Patents Granted
202435
2023209
2022154
20212012
20201514
2019367
2017152
20163
20151
201411

How many Mabworks Biotech patents are Alive/Dead?

Worldwide Patents

Mabworks Biotech Patent Portfolio

How Many Patents did Mabworks Biotech File in Different Countries?

Mabworks Biotech Worldwide Patent Filing

Countries in which Mabworks Biotech Filed Patents

CountryPatents
China56
United States of America23
Hong Kong (S.A.R.)21
Europe (EPO)9
Australia9
Canada5
Germany2
Taiwan2
Austria1
Japan1

Where are Research Centers of Mabworks Biotech Patents Located?

R&D Centres of Mabworks Biotech

10 Best Mabworks Biotech Patents

US10421817B1 is the most popular patent in the Mabworks Biotech portfolio. It has received 19 citations so far from companies like Novarock Biotherapeutics, Rongchang Biopharmaceuticals (Yantai), Courreges Medical Company.

Below is the list of 10 most cited patents of Mabworks Biotech:

Publication NumberCitation Count
US10421817B119
US10570210B112
WO2018014864A112
CN101653749A11
CN1896229A10
US9745382B18
CN107446045A8
CN1523350A8
WO2020147321A17
CN104278038A6

What are Mabworks Biotech key innovation segments?

What Technologies are Covered by Mabworks Biotech?

The chart below distributes patents filed by Mabworks Biotech in different countries on the basis of the technology protected in patents. It also represents the markets where Mabworks Biotech thinks it’s important to protect particular technology inventions.

R&D Focus: How has Mabworks Biotech search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Mabworks Biotech?

Related Articles

Banuba Patents – Insights & Stats (Updated 2024)

Banuba has a total of 40 patents globally, out of which 26 have been granted. Of these 40 patents, more than 27% patents are active. The United States of America is where Banuba has filed the maximum number of patents, followed by Australia and Europe (EPO). Parallelly, United States of

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.